61
Participants
Start Date
December 13, 2019
Primary Completion Date
March 26, 2021
Study Completion Date
March 26, 2021
Facebook Group
The pilot trial, a two-arm, parallel groups, randomized controlled design, will enroll 60 participants randomized with 1:1 allocation to the intervention or control condition. Participants will be randomized within stratified blocks based on sex (male, female), age group (19-29, 30-49, 50+ years), and region (urban, rural); potential variables related to outcomes. Assessments will be conducted for both study groups at baseline and at 1, 3, and 6 month follow-up.
Mayo Clinic in Rochester, Rochester
Lead Sponsor
National Institute on Drug Abuse (NIDA)
NIH
Mayo Clinic
OTHER